Clinical Impact of EGFR vs KRAS Mutations in Multifocal Lung Adenocarcinoma

被引：0
|
作者：
Jiang, J. [1 ]
Berry, M. F. [1 ]
Lui, N. S. [1 ]
Liou, D. Z. [1 ]
Trope, W. L. [1 ]
Backhus, L. M. [1 ]
Shrager, J. B. [1 ]
机构：
[1] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
multifocal lung adenocarcinoma; EGFR; KRAS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP06.03-06
引用
下载
收藏
页码：S484 / S485
页数：2
相关论文
共 50 条
  • [31] The Role of EGFR and KRAS Mutations in Locally Advanced Lung Adenocarcinoma Treated With Definitive Radiation Therapy
    Rimner, A.
    Wang, H.
    Tsang, M.
    Drilon, A. D.
    Paik, P. K.
    Hsu, M.
    Zhang, Z.
    Rosenzweig, K. E.
    Wu, A. J.
    Zakowski, M. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S579 - S579
  • [32] CLINICOPATHOLOGICAL FEATURES OF LUNG ADENOCARCINOMA WITH KRAS MUTATIONS
    Kakegawa, Seiichi
    Shimizu, Kimihiro
    Nakano, Tetsuhiro
    Sugano, Masayuki
    Miyamae, Yohei
    Kamiyoshihara, Mitsuhiro
    Kawashima, Osamu
    Takeyoshi, Izumi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S986 - S986
  • [33] Clinicopathological Features of Lung Adenocarcinoma With KRAS Mutations
    Kakegawa, Seiichi
    Shimizu, Kimihiro
    Sugano, Masayuki
    Miyamae, Yohei
    Kaira, Kyoichi
    Araki, Takuya
    Nakano, Tetsuhiro
    Kamiyoshihara, Mitsuhiro
    Kawashima, Osamu
    Takeyoshi, Izumi
    CANCER, 2011, 117 (18) : 4257 - 4266
  • [34] EGFR and KRAS Mutational Analyses in Metastatic Lung Adenocarcinoma
    Munfus-McCray, Delicia
    Askin, Frederic
    Clark, Douglas
    Adams, Christina
    Gabrielson, Edward
    Li, Qing Kay
    CANCER CYTOPATHOLOGY, 2010, 118 (05) : 369 - 369
  • [35] Field defect abnormalities in lung adenocarcinoma: KRAS vs. EGFR mutant tumors.
    Tang, Ximing
    Bi, Xiaoquin
    Ozburn, Natalie
    Hong, Waun Ki
    Wistuba, Ignacio I.
    CANCER RESEARCH, 2006, 66 (08)
  • [36] Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung
    Kim, Young Tae
    Kim, Tae-you
    Lee, Dong Soon
    Park, Sun Jung
    Park, Ju-Yeon
    Seo, Soon-Jung
    Choi, Hyo-Seon
    Kang, Hee Jung
    Hahn, Seokyung
    Kang, Chang Hyun
    Sung, Sook Whan
    Kim, Joo Hyun
    LUNG CANCER, 2008, 59 (01) : 111 - 118
  • [37] Concurrent EGFR and ALK Mutations in KRAS-Mutant Lung Adenocarcinomas and Their Clinical Behavior
    Wood, Kevin C.
    Hensing, Thomas
    Won, Brian
    Vokes, Everett
    Salgia, Ravi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S453 - S454
  • [38] Comparison of CT radiogenomic and clinical characteristics between EGFR and KRAS mutations in lung adenocarcinomas
    Lv, J.
    Zhang, H.
    Ma, J.
    Ma, Y.
    Gao, G.
    Song, Z.
    Yang, Y.
    CLINICAL RADIOLOGY, 2018, 73 (06) : 590.e1 - 590.e8
  • [39] EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect
    Sahnane, Nora
    Frattini, Milo
    Bernasconi, Barbara
    Zappa, Francesco
    Schiavone, Giovanna
    Wannesson, Luciano
    Antonelli, Paola
    Balzarini, Piera
    Sessa, Fausto
    Mazzucchelli, Luca
    Tibiletti, Maria Grazia
    Martin, Vittoria
    CLINICAL LUNG CANCER, 2016, 17 (01) : 56 - 61
  • [40] In vivo oncogenic conflict triggered by co-existing KRAS and EGFR activating mutations in lung adenocarcinoma
    Ambrogio, C.
    Barbacid, M.
    Santamaria, D.
    ONCOGENE, 2017, 36 (16) : 2309 - 2318
12345